Pembrolizumab with olaparib and chemoradiation for previously untreated limited-stage small-cell lung cancer

Small cell lung cancer (SCLC) is an aggressive (fast-growing) cancer that forms in tissues of the
lung and can spread to other parts of the body. Limited stage SCLC (LS-SCLC) means the cancer
cells can be seen in one lung and in nearby lymph nodes. SCLC can affect anyone, but it typically
affects people who have a long history of tobacco use. Some symptoms include chest discomfort,
coughing up blood, shortness of breath. LS-SCLC remains a challenging disease with current
standard of care treatment despite improvements in diagnosis and therapy during the past years.